We're not for everyone.
We’re for those who believe uniting evidence and access improves patient outcomes.
We connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation.
Accelerating Patient Outcomes for Biopharma
We partner with biopharma to modernize evidence development and patient access pathways, ensuring therapies are safe, effective, and available to those who need them. We transform how therapies reach and serve patients by integrating real-world evidence, risk management, and a deep understanding of the patient journey. Our customized solutions leverage unrivaled expertise, real-world data, and the latest technologies to demonstrate long-term product value and support better patient outcomes.
Explore Biopharma Solutions
Purpose-built solutions to deliver the evidence required to inform stakeholder decision making.
Evidence Development
Our expert-led evidence generation solutions are designed to deliver the critical data required to inform stakeholder decision-making at every step. From modernized study designs and execution to late-stage research, we develop comprehensive real-world evidence strategies that align with the expectations of patients, providers, regulators, and payers. We guide you through the complexities of approval, commercialization, and the demonstration of long-term product value for your therapies.
Safety & Risk Management
We provide comprehensive, tailored drug safety and global risk management solutions that are sophisticated, tech-enabled, and regulatory compliant. Drawing on decades of experience, our strategies are crafted to meticulously address the benefit/risk profile of specialty therapies and ensure every decision is expertly informed. As a recognized leader in Risk Evaluation and Mitigation Strategies (REMS), we deliver an integrated approach to pharmacovigilance and drug safety services that optimizes your program and gives you peace of mind.
Patient Access
Our targeted approach combines high-tech and high-touch care to provide exceptional patient access, affordability, and adherence solutions. By building a seamless and scalable experience, we strategically address complex payer and insurance hurdles, ensuring your therapy reaches the patients who need it most and solidifying long-term product success and value creation.
Expertise that unites real-world evidence and patient access to improve outcomes.
UBC brings together seasoned professionals specializing in specialty therapies across risk management, evidence development, and patient access. Providing collaborative, expert-driven solutions tailored to your program, we are driven by a commitment to overcoming the barriers between your therapy and the patients that need it most. We leverage unrivaled expertise, real-world data and the latest technologies to provide the insights you need to mitigate risk, demonstrate long-term product value, ensure access, and support better patient outcomes.
Explore Biopharma Services
Purpose-built solutions to deliver the evidence required to inform stakeholder decision making.
Evidence Development
Expert-led evidence generation solutions to guide you through every step of program design and delivery, from modernized study designs to late-stage research. We develop real-world evidence strategies that align with the expectations of patients, providers, regulators, and payers — and help you navigate the complexities of approval, commercialization, and delivery of long-term outcomes.
Safety & Risk Management
Comprehensive, tailored drug safety and global risk management solutions that are sophisticated, tech-enabled, and regulatory compliant. Our decades of experience drive strategies to address the benefit/risk profile of specialty therapies, optimize pharmacovigilance, and ensure every decision is informed.
Patient Access
A targeted approach that integrates high-tech and high-touch care for exceptional patient access, affordability, and adherence solutions. Purpose-built to fit unique patient health journeys, our patient access support addresses payer and insurance hurdles while building a seamless, scalable experience and enhancing patient outcomes.
Insights
Navigating 2026: Patient service themes, challenges, and solutions
As we look ahead to 2026, patient access and support services face growing complexity—from affordability challenges and evolving care models to the rise of specialty therapies. This blog explores the key trends shaping the healthcare landscape and offers strategic solutions, including AI-powered innovation, digital transformation, and partnerships that drive better outcomes. Discover how UBC is leading the way with patient-first strategies to simplify the patient and product journey.
News
UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities
United BioSource LLC (UBC) has acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical and economic analysis.
Events
DIA’s Global Pharmacovigilance and Risk Management Strategies Conference 2026
Join UBC at DIA’s Global Pharmacovigilance and Risk Management Strategies Conference. Connect with our Safety & Risk Management experts to learn how we deliver end-to-end pharmacovigilance services, REMS program design, and proven compliance strategies that prioritize patient safety.
